Your browser is no longer supported. Please, upgrade your browser.
111, Inc.
Index- P/E- EPS (ttm)-0.91 Insider Own- Shs Outstand82.43M Perf Week-7.08%
Market Cap1.81B Forward P/E- EPS next Y-0.27 Insider Trans- Shs Float46.11M Perf Month72.90%
Income-74.50M PEG- EPS next Q- Inst Own11.90% Short Float0.53% Perf Quarter191.97%
Sales1.06B P/S1.70 EPS this Y-31.00% Inst Trans26.29% Short Ratio0.26 Perf Half Y224.04%
Book/sh0.90 P/B22.61 EPS next Y25.00% ROA-24.60% Target Price15.91 Perf Year204.64%
Cash/sh1.96 P/C10.41 EPS next 5Y- ROE-76.50% 52W Range5.20 - 45.88 Perf YTD192.81%
Dividend- P/FCF- EPS past 5Y- ROI-56.20% 52W High-55.65% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin4.40% 52W Low291.35% ATR3.89
Employees1932 Current Ratio1.50 Sales Q/Q112.80% Oper. Margin-7.20% RSI (14)59.42 Volatility17.82% 21.83%
OptionableNo Debt/Eq0.37 EPS Q/Q12.30% Profit Margin-7.00% Rel Volume2.15 Prev Close20.30
ShortableYes LT Debt/Eq0.00 EarningsNov 19 BMO Payout- Avg Volume924.95K Price20.35
Recom1.00 SMA2016.67% SMA5078.68% SMA200159.16% Volume1,992,973 Change0.25%
Feb-05-21 06:00AM  
Jan-01-21 03:24AM  
Dec-22-20 04:22AM  
Nov-29-20 11:42AM  
Nov-19-20 05:00AM  
Oct-22-20 06:00AM  
Oct-19-20 06:50AM  
Oct-15-20 05:40PM  
Sep-30-20 06:00AM  
Sep-23-20 12:53PM  
Sep-04-20 06:22AM  
Aug-20-20 04:35AM  
Jul-31-20 06:00AM  
Jul-27-20 06:00AM  
May-27-20 03:44PM  
May-21-20 04:30AM  
May-15-20 11:55AM  
May-08-20 06:00AM  
May-07-20 05:55AM  
May-06-20 05:51AM  
May-04-20 06:51AM  
Apr-17-20 01:58AM  
Mar-27-20 07:30AM  
Mar-19-20 08:10AM  
Mar-16-20 12:38PM  
Mar-12-20 06:00AM  
Feb-24-20 03:00AM  
Feb-20-20 04:15AM  
Feb-11-20 05:00PM  
Feb-04-20 06:39AM  
Jan-19-20 05:00AM  
Jan-17-20 08:00AM  
Jan-13-20 05:30AM  
Jan-07-20 12:24PM  
Jan-03-20 07:00PM  
Dec-31-19 12:00PM  
Dec-19-19 08:00AM  
Nov-27-19 05:20PM  
Nov-14-19 04:56AM  
Oct-25-19 08:00AM  
Oct-10-19 08:31AM  
Sep-30-19 10:05AM  
Sep-12-19 11:16AM  
Sep-04-19 11:28AM  
Aug-23-19 09:20AM  
Aug-15-19 03:08PM  
Aug-07-19 08:00PM  
Aug-01-19 08:00AM  
Jul-24-19 08:00AM  
Jul-23-19 09:53AM  
Jun-13-19 01:45PM  
May-31-19 07:15AM  
May-24-19 09:21AM  
May-16-19 06:15AM  
111, Inc., through its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2B and B2C. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services, such as online consultation services and e-prescription services to consumers. Its product portfolio comprises prescription and over-the counter drugs, such as western and traditional Chinese medicinal drugs; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices, including bandages and thermometers; and personal care products, such as skin care, birth control, and sexual wellness products; and baby products. The company also operates an online marketplace where third-party sellers can directly sell to pharmacies; provides online loan application services to the clients of 1 Drug Mall, including pharmacies and wholesalers; and digital contract sales organization and data services. As of December 31, 2019, it operated 12 offline retail pharmacies under the Yi Hao Pharmacy brand name in Guangzhou, Shanghai, Tianjin, and Kunshan. In addition, the company offers warehousing, logistics, procurement, research and development, and consulting services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies and distributors, medical professionals, and insurance companies. 111, Inc. has a strategic partnership with Bayer Healthcare Co. Ltd. to develop a digitalized content portal that would provide online pharmacist training and interactive patient education content and services. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.